Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × NSC 366140 × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2 Sarcoma 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 69 Paclitaxel 46 Tamoxifen 35 Trastuzumab 34 Doxorubicin 34 Magnetic Resonance Spectroscopy 31 Specimen Handling 29 Radiotherapy 29 Docetaxel 29 Taxes 26 Chemotherapy, Adjuvant 24 Fluorouracil 23 Filgrastim 20 Carboplatin 20 Biopsy 19 Epirubicin 18 Neoadjuvant Therapy 17 Methotrexate 17 Peripheral Blood Stem Cell Transplantation 16 aldesleukin 14 Lapatinib 13 Bevacizumab 13 Anastrozole 13 exemestane 12 Fulvestrant 11 Capecitabine 11 CMF regimen 11 veliparib 9 sargramostim 9 fludarabine 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003041 2013-01-31

Pyrazoloacridine in Treating Women With Refractory Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡